NL-OMON37543
Completed
Not Applicable
Administration of Topical Ophthalmic Medication (ATOM): Feasibility of the spraynozzle technique. - ATOM
Medspray XMEMS BV0 sites20 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- n.v.t. onderzoek wordt verricht op gezonde vrijwilligers
- Sponsor
- Medspray XMEMS BV
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy volunteers with healthy eyes.
- •Informed consent.
- •Age \> 18 years.
Exclusion Criteria
- •Allergy/hypersensitivity for fluorescein.
- •Previous ocular surgery, including refractive laser surgery.
- •Corneal condition (e.g. Sjögren, punctata).
- •Contact lens wear.
- •Active epithelial HSV keratitis.
- •Pregnancy.;Concurrent use of eye drops.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Administration of Topical Ophthalmic Medication (ATOM): Feasibility of the spraynozzle technique.Ophthalmic drug dispersal.NL-OMON28128Medspray XMEMS BVColosseum 237521 PV Enschedethe Netherlands053 711 28 35info@medspray.nl20
Not yet recruiting
Phase 2
application of guduchi ghrita as eye drop in an allergic eye disease named vernal keratoconjunctivitis.CTRI/2023/01/049304Department of Shalakya Tantra
Completed
Phase 4
A clinical trial to study the effect of Timolol eyedrops in patients with acute migraineCTRI/2015/05/005829Dr Abraham Kurian50
Recruiting
Not Applicable
Clinical study about ophthalmic local administrations of Triamcinolone acetonide for macular edema and/or retinal periphlebitisJPRN-UMIN000005778Department of Ophthalmology and Visual Sciences, Yamagata University School of Medicine100
Completed
Not Applicable
The use of hospital-prepared ophthalmic solution of 0.1% amphotericin Bfungal keratitisJPRN-UMIN000017319Gunma University Graduate School of Medicine, Department of Ophthalmology20